May 16, 2007 — Monebo Technologies Inc. has announced that the CardioBelt Electrode System is now available, following clearance by the FDA.
The CardioBelt is an ECG acquisition device used for remote patient monitoring, including the assessment of heart arrhythmias. It will be integrated into the platform technologies of home heath care and telemedicine equipment providers, in devices ranging from computers to cell phones, and will work in concert with other devices that monitor blood pressure, weight, glucose level, and oxygen saturation, to provide physicians a more complete assessment of their patients health while the patient stays in the comfort of their own home.
The CardioBelt is designed for patient ease of use, and to allow healthcare professionals to quickly obtain accurate information on their patient's ECG. It is worn across the chest, with no patient preparation, sticky electrodes or cables, eliminating the need for a trained health professional to be physically present. The patient puts the belt on, pushes one button, and the CardioBelt connects wirelessly to a communication device, leaving the patient with total mobility.
CardioBelt works with Monebo's ECGAnalyzer software, designed for the healthcare professional and used to interpret the ECG signal once it is received at the central location. It provides easy to use, yet powerful ECG monitoring tools, and helps with the efficiency of handling multiple patients. Together, the system provides a cost effective and patient liberating solution to cardiac electrical monitoring, making it an excellent alternative for patients in a homecare or distance care setting.
For more information visit www.monebo.com
March 06, 2026 
